HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart.

AbstractOBJECTIVES:
The purpose of this study was to investigate the role of plasminogen (Plg) in stem cell-mediated cardiac repair and regeneration after myocardial infarction (MI).
BACKGROUND:
An MI induces irreversible tissue damage, eventually leading to heart failure. Bone marrow (BM)-derived stem cells promote tissue repair and regeneration after MI. Thrombolytic treatment with Plg activators significantly improves the clinical outcome in MI by restoring cardiac perfusion. However, the role of Plg in stem cell-mediated cardiac repair remains unclear.
METHODS:
An MI was induced in Plg-deficient (Plg(-/-)) and wild-type (Plg(+/+)) mice by ligation of the left anterior descending coronary artery. Stem cells were visualized by in vivo tracking of green fluorescent protein (GFP)-expressing BM cells after BM transplantation. Cardiac function, stem cell homing, and signaling pathways downstream of Plg were examined.
RESULTS:
Granulocyte colony-stimulating factor, a stem cell mobilizer, significantly promoted BM-derived stem cell (GFP(+)c-kit(+) cell) recruitment into the infarcted heart and stem cell-mediated cardiac repair in Plg(+/+) mice. However, Plg deficiency markedly inhibited stem cell homing and cardiac repair, suggesting that Plg is critical for stem cell-mediated cardiac repair. Moreover, Plg regulated C-X-C chemokine receptor type 4 (CXCR4) expression in stem cells in vivo and in vitro through matrix metalloproteinase-9. Lentiviral reconstitution of CXCR4 expression in BM cells successfully rescued stem cell homing to the infarcted heart in Plg-deficient mice, indicating that CXCR4 has a critical role in Plg-mediated stem cell homing after MI.
CONCLUSIONS:
These findings have identified a novel role for Plg in stem cell-mediated cardiac repair after MI. Thus, targeting Plg may offer a new therapeutic strategy for stem cell-mediated cardiac repair after MI.
AuthorsYanqing Gong, Yujing Zhao, Ying Li, Yi Fan, Jane Hoover-Plow
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 63 Issue 25 Pt A Pg. 2862-72 (Jul 01 2014) ISSN: 1558-3597 [Electronic] United States
PMID24681141 (Publication Type: Journal Article)
CopyrightCopyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Fibrinolytic Agents
  • Plasminogen
Topics
  • Animals
  • Bone Marrow Transplantation (methods)
  • Disease Models, Animal
  • Fibrinolytic Agents (therapeutic use)
  • Heart Failure (etiology, prevention & control)
  • Hematopoietic Stem Cell Mobilization (methods)
  • Mice
  • Myocardial Infarction (complications, physiopathology, therapy)
  • Plasminogen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: